TEX13A

Across TCGA pan-cancer cohorts, TEX13A RNA is linked to patient survival in 13 of 34 cancer types, making it the most broadly survival-associated TEX13A data layer compared with 8 for mutation status.

The strongest signal is observed in thyroid carcinoma (THCA), where higher TEX13A RNA is associated with worse overall survival. In most high-consensus cancer types, elevated TEX13A expression acts as an unfavorable survival marker, although some lineages such as BLCA show a favorable association.

THCA, READ, and BLCA are the cancer types where TEX13A RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THCA	OS	Tertile	All	0.911	0.995	<.001	126	view →
READ	OS	Tertile	II,III,IV	0.111	0.919	<.001	93	view →
BLCA	OS	Tertile	All	0.849	0.389	.001	63	view →
LIHC	OS	Tertile	II,III,IV	0.166	0.701	<.001	51	view →
LUSC	OS	Tertile	IV	0.001	0.673	.014	45	view →
ACC	DFS	Tertile	All	0.115	0.633	.015	36	view →
PAAD	DFS	Tertile	All	0.181	0.511	.018	27	view →
SCLC	DFS	Tertile	II,III,IV	0.247	0.797	.016	27	view →
THYM	DFS	Tertile	II,III,IV	0.621	0.933	.009	18	view →
MESO	OS	Tertile	IV	0.077	0.592	.019	18	view →
LUAD	OS	Tertile	All	0.415	0.676	.040	18	view →
KIRC	DFS	Tertile	All	0.403	0.645	.024	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 13 lineages.

TEX13A–THCA (OS)

Open the THCA breakdown →